NYSE: MCMoelis & Co Stock
$78.51-0.29 (-0.37%)
Updated Feb 10, 2025
MC Price
$78.51
Fair Value Price
N/A
Market Cap
$5.88B
52 Week Low
$46.24
52 Week High
$82.89
P/E
137.74x
P/B
16x
P/S
5.28x
PEG
0.48x
Dividend Yield
3.06%
Revenue
$970.70M
Earnings
$40.96M
Gross Margin
100%
Operating Margin
5.16%
Profit Margin
4.2%
Debt to Equity
2.06
Operating Cash Flow
$211M
Beta
1.11
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MC Overview
Moelis & Company offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters in North and South America, Europe, Middle East, Asia, and Australia. It provides services to public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, governments, and sovereign wealth funds. Moelis & Company was founded in 2007 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MC's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
D
Value
B
Growth
B
Momentum
B
Sentiment
C
Safety
B
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Capital Market
Industry Rating
D
MC
Ranked#5 of 56
Ranked#5 of 56
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.21 | A | |
| $38.34 | A | |
| $9.63 | B |
Be the first to know about important MC news, forecast changes, insider trades & much more!
MC News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MC ($78.51) is trading above its intrinsic value of $58.02, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MC is poor value based on its earnings relative to its share price (137.74x), compared to the US market average (31x)
P/E vs Market Valuation
MC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MC due diligence checks available for Premium users.
Valuation
MC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
137.74x
Industry
28.04x
Market
31x
MC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
16x
Industry
2.44x
MC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MC price to earnings growth (PEG)
For valuing profitable companies with growth potential
MC is good value based... subscribe to Premium to read more.
PEG Value Valuation
MC's financial health
Profit margin
Revenue
$273.8M
Net Income
$16.9M
Profit Margin
6.2%
MC's Earnings (EBIT) of $50.04M... subscribe to Premium to read more.
Interest Coverage Financials
MC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.2B
Liabilities
$758.0M
Debt to equity
2.06
MC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$137.2M
Investing
-$95.3M
Financing
-$48.6M
MC's operating cash flow ($211.48M)... subscribe to Premium to read more.
Debt Coverage Financials
MC vs Capital Market Stocks
Moelis & Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.